Skip to search formSkip to main contentSkip to account menu

2,6-diisopropylphenyl-4-hydroxybutanote disodium phosphate

Known as: HX0969w 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Organophosphorus Compounds

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
[The sedative-hypnotic effects and safety of oral administrated propofol prodrugs hx0969w and fospropofol disodiun in comparison with propofol emulsion in rats].
OBJECTIVE To estimate the median effective dose (EDs0) of oral administrated HX0969w, fospropofol disodium and propofol emulsion… 
2014
2014
TEST OF THE PRODRUGS BIOCONVERSION IN RAT PLASMA , RHESUS MONKEY PLASMA , AND RAT HEPATIC MICROSOMES Hydrolysis in Rat Plasma and in Rhesus Monkey Plasma
• Volume 118 • Number 4 www.anesthesia-analgesia.org 745 As a commonly used IV sedative hypnotic drug, propofol has rapid onset… 
2012
2012
Effects of a new intravenous anesthetic HX0969w on spontaneous locomotion activity in mice
OBJECTIVE To examine the effects of a new intravenous anesthetic HX0969w on spontaneous locomotor activity in mice.METHODS 60… 
2011
2011
Determination of HX0969w in Rabbit Whole Blood by Liquid Chromatography—Tandem Mass Spectrometry and its Application in a Pharmacokinetic Study
HX0969w is a novel carboxylate ester prodrug of propofol. After intravenous administration of HX0969w, the compound is rapidly… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)